Qureight today announces that we have gained ISO13485 certification

15 Sep 22

Qureight has met the requirements to use our quality management system for the design of medical devices. We are pleased as it shows our dedication to maintaining a high quality QMS as we continue to develop our platform.

Qureight announces its Scientific Advisory Board for Idiopathic Pulmonary Fibrosis (IPF)

23 Aug 22

Qureight today announces its Scientific Advisory Board for Idiopathic Pulmonary Fibrosis (IPF). This progressive scarring lung disease is one of the company’s three benchmark conditions alongside...

Qureight and the Royal Brompton Hospital, part of Guy’s and St Thomas’ NHS Foundation Trust, Announce Research Agreement to Apply Image Analysis Techniques to the PROFILE Study Dataset

18 Feb 21

Study aims to investigate correlations between image and serum collagen biomarkers to advance the clinical measurement of progression in fibrotic lung diseases.

Qureight appoints Darren Gallagher as Chief Technology Officer

18 Jan 21

Darren brings 20 years of big data platform engineering experience as Qureight builds out its senior team post pre-seed investment.

Find out more

If you would like to find out more about our company and our technology please get in touch.

info@qureight.com